{"result": "(\"entity\"<|>ESPEN<|>ORGANIZATION<|>ESPEN is a society that focuses on clinical nutrition guidelines and has published various guidelines since 2006, adapting methodologies to the GRADE system.)\n##\n(\"entity\"<|>ASPEN<|>ORGANIZATION<|>ASPEN is a society that has developed clinical nutrition guidelines and has coordinated efforts with ESPEN for common guidelines.)\n##\n(\"entity\"<|>CANADIAN CRITICAL CARE PRACTICE GUIDELINES<|>ORGANIZATION<|>CCPG focuses on nutritional support for critically ill patients and has been updated frequently since its first publication in 2003.)\n##\n(\"entity\"<|>NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE<|>ORGANIZATION<|>NICE provides clinical guidelines in the UK, with a focus on evidence-based recommendations since 2006.)\n##\n(\"entity\"<|>GORDON JENSEN<|>PERSON<|>Gordon Jensen is a key figure who directed a committee aimed at creating common guidelines for nutritional support.)\n##\n(\"entity\"<|>ALASTAIR FORBES<|>PERSON<|>Alastair Forbes is a key figure who coordinated efforts with Gordon Jensen in the development of common nutritional guidelines.)\n##\n(\"entity\"<|>GRADE<|>EVENT<|>GRADE is a system used for evaluating the quality of evidence and strength of recommendations in clinical guidelines.)\n##\n(\"entity\"<|>MEDICINA BASADA EN PRUEBAS<|>EVENT<|>Evidence-based medicine aims to integrate clinical research with personal clinical experience and patient values to improve care.)\n##\n(\"relationship\"<|>ESPEN<|>ASPEN<|>ESPEN and ASPEN have coordinated efforts to develop common clinical nutrition guidelines<|>7)\n##\n(\"relationship\"<|>CANADIAN CRITICAL CARE PRACTICE GUIDELINES<|>ESPEN<|>CCPG guidelines are influenced by the practices and recommendations of ESPEN<|>5)\n##\n(\"relationship\"<|>NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE<|>ESPEN<|>NICE guidelines are compared to those of ESPEN, highlighting differences in evidence and recommendations<|>4)\n##\n(\"relationship\"<|>GORDON JENSEN<|>ESPEN<|>Gordon Jensen is involved in the efforts of ESPEN to create common guidelines<|>6)\n##\n(\"relationship\"<|>ALASTAIR FORBES<|>ESPEN<|>Alastair Forbes coordinated with ESPEN in the development of common nutritional guidelines<|>6)\n##\n(\"relationship\"<|>GRADE<|>ESPEN<|>ESPEN has adapted its methodologies to the GRADE system for evaluating evidence<|>5)\n##\n(\"relationship\"<|>MEDICINA BASADA EN PRUEBAS<|>ESPEN<|>ESPEN's guidelines are influenced by the principles of evidence-based medicine<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 2+ | Estudios de cohortes o de casos y controles o estudios de pruebas diagnósticas bien realizadas con bajo riesgo de sesgo y con una moderada probabilidad de establecer una relación causal |\n| 2- | Estudios de cohortes o de casos y controles con alto riesgo de sesgo |\n| 3 | Estudios no analíticos, como informes de casos y series de casos |\n| 4 | Opinión de expertos |\n| Fuerza de las recomendaciones |\n| A | Al menos un metanálisis, revisión sistemática de ensayos controlados aleatorizados (ECA), o ECA de nivel 1++, directamente aplicables a la población diana, o evidencia suficiente derivada de estudios de nivel 1+, directamente aplicable a la población diana y que demuestren consistencia global en los resultados |\n| B | Evidencia suficiente derivada de estudios de nivel 2++, directamente aplicable a la población diana y que demuestren consistencia global en los resultados. Evidencia extrapolada de estudios de nivel 1++ o 1+ |\n| 0 | Evidencia de nivel 3 o 4. Evidencia extrapolada de estudios de nivel 2++ o 2+ |\n| Buena práctica clínica/consenso expertos | Práctica recomendada basada en la experiencia clínica y el consenso del equipo redactor |\n---\nTema 59. Nutrición basada en la evidencia 933\n\nel formato de las guías, para centrarse en situaciones clínicas y grupos de edad concretos. Reciente-mente ha modificado también la metodología, para adaptarla al sistema GRADE. Sus GPC están disponibles en http://www.nutritioncare.org/gui-delines_and_clinical_resources.\n\n- ESPEN: en un inicio, sus guías consistieron en un compendio de nutrición enteral (2006) y parente-ral (2009). En los últimos años se ha centrado tam-bién en situaciones clínicas concretas (http://www. espen.org/education/espen-guidelines). En 2015, publicó sus procedimientos operativos para el de-sarrollo de sus GPC, en los que explica que ha em-pleado la clasificación de la evidencia de SIGN, di-ficultando nuevamente una posible comparación con las guías de ASPEN30.\n\n- Canadian Critical Care Practice Guidelines (CCPG, http://criticalcarenutrition.com/): se centran exclu-sivamente en el soporte nutricional del paciente crítico. Fueron publicadas por vez primera en 2003 y han sido actualizadas con más frecuencia que las del resto de Sociedades (2005, 2007, 2009, 2013, 2015), en consonancia con la rápida evolución de los conocimientos en nutrición.\n\n- Esto último nos sirve también para poner en cues-tión las GPC inglesas del National Institute for Cli-nica Excellence (NICE, https://www.nice.org.uk/ guidance/cg32), que se remontan a 2006. Aun-que fueron revisadas en 2014, los autores dijeron no encontrar evidencias para modificar sus reco-mendaciones, y no serán reevaluadas hasta 2018.\n\nPara facilitar el manejo nutricional de los pacientes se-ría de gran utilidad que las sociedades científicas implica-das en ello elaboraran unas guías comunes, una idea que inició su desarrollo hace unos años, a través de la crea-ción de un comité dirigido por Gordon Jensen y Alastair Forbes, en el que ESPEN y ASPEN coordinaron esfuer-zos39, pero que no se ha repetido por el momento.\n\n## 9. Conclusiones\n\nLo que pretende la medicina basada en pruebas es que la práctica clínica se adecúe a la investigación clíni-ca disponible, de modo que, una vez localizada y eva-luada por el médico, sea aplicada para mejorar el cui-dado de sus pacientes y su propia práctica. La MBE, en cualquier caso, no se reduce a la evidencia, sino que trata de integrar esta con la experiencia clínica personal y con los valores y preferencias de los pacientes. El so-porte nutricional ha sido una de las intervenciones te-rapéuticas más controvertidas en la medicina moder-na, pero en los últimos años, y a pesar de las dificultades para la aplicación de la MBE a la nutrición, se ha incre-mentado la evidencia sobre la efectividad de la nutri-ción clínica40, 41. Nuestras decisiones clínicas deberían, en lo posible, estar basadas en pruebas, integrando,\n\ncomo se ha mencionado, la mejor evidencia científica disponible con la experiencia clínica y los valores y pre-ferencias de nuestros pacientes. Aunque, en ausencia de evidencia suficiente, siempre nos quedarán otras alternativas42, que con buen humor nos recuerdan que la Medicina sigue siendo un arte, además de una cien-cia: la medicina basada en la eminencia, la medicina basada en la vehemencia, la medicina basada en la elo-cuencia, la medicina basada en la providencia\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}